SE0200154D0 - New process - Google Patents

New process

Info

Publication number
SE0200154D0
SE0200154D0 SE0200154A SE0200154A SE0200154D0 SE 0200154 D0 SE0200154 D0 SE 0200154D0 SE 0200154 A SE0200154 A SE 0200154A SE 0200154 A SE0200154 A SE 0200154A SE 0200154 D0 SE0200154 D0 SE 0200154D0
Authority
SE
Sweden
Prior art keywords
granules
semi
self
mixed
refers
Prior art date
Application number
SE0200154A
Other languages
English (en)
Inventor
Jari Alander
Staffan Norberg
Henri Hansson
Lars Hovgaard
Marianne Svaerd
Original Assignee
Galenica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenica Ab filed Critical Galenica Ab
Priority to SE0200154A priority Critical patent/SE0200154D0/sv
Publication of SE0200154D0 publication Critical patent/SE0200154D0/sv
Priority to EP03701205A priority patent/EP1467708A1/en
Priority to US10/501,873 priority patent/US7422757B2/en
Priority to US10/501,899 priority patent/US20050084526A1/en
Priority to PCT/SE2003/000093 priority patent/WO2003061630A1/en
Priority to PCT/SE2003/000092 priority patent/WO2003061627A1/en
Priority to EP03701206.9A priority patent/EP1467713B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE0200154A 2002-01-21 2002-01-21 New process SE0200154D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0200154A SE0200154D0 (sv) 2002-01-21 2002-01-21 New process
EP03701205A EP1467708A1 (en) 2002-01-21 2003-01-21 New process 1
US10/501,873 US7422757B2 (en) 2002-01-21 2003-01-21 Tabletting process
US10/501,899 US20050084526A1 (en) 2002-01-21 2003-01-21 New process 1
PCT/SE2003/000093 WO2003061630A1 (en) 2002-01-21 2003-01-21 Tabletting process
PCT/SE2003/000092 WO2003061627A1 (en) 2002-01-21 2003-01-21 New process 1
EP03701206.9A EP1467713B1 (en) 2002-01-21 2003-01-21 Tabletting process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200154A SE0200154D0 (sv) 2002-01-21 2002-01-21 New process

Publications (1)

Publication Number Publication Date
SE0200154D0 true SE0200154D0 (sv) 2002-01-21

Family

ID=20286712

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200154A SE0200154D0 (sv) 2002-01-21 2002-01-21 New process

Country Status (4)

Country Link
US (2) US20050084526A1 (sv)
EP (2) EP1467713B1 (sv)
SE (1) SE0200154D0 (sv)
WO (2) WO2003061627A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200154D0 (sv) * 2002-01-21 2002-01-21 Galenica Ab New process
WO2005065715A1 (ja) * 2003-12-25 2005-07-21 Takeda Pharmaceutical Company Limited 造粒性改善方法
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
CA2620738C (en) * 2005-08-31 2010-10-12 Ezaki Glico Co., Ltd. Tablet for removing tongue coating
ATE489077T1 (de) 2006-09-28 2010-12-15 Losan Pharma Gmbh Schnell lösliche formulierung von nichtsteroidalen antiphlogistika
US8202456B2 (en) * 2006-11-13 2012-06-19 Kyorin Pharmaceutical Co., Ltd. Method for preparing sustained release tablet
WO2008079342A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
EP2101739A2 (en) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
MX2010011962A (es) * 2008-04-30 2010-11-30 Novartis Ag Proceso continuo para hacer composiciones farmaceuticas.
IT1400695B1 (it) * 2010-06-21 2013-06-28 Labomar S R L Composizioni farmaceutiche e/o nutraceutiche contenenti principi attivi insolubili in acqua e procedimento per ottenerle.
ITMI20111259A1 (it) * 2011-07-06 2013-01-07 Eye Tech Srl Composizione orosolubile a rapida disgregazione contenente derivati di curcumina
CN104284599B (zh) * 2012-03-07 2018-08-17 阿尔托大学基金会 纯纤维素在提高饲料能量含量中的用途
CN106399102A (zh) * 2016-09-14 2017-02-15 青岛佳明测控科技股份有限公司 微生物颗粒培养基的简便制备方法
JP7671693B2 (ja) 2018-10-23 2025-05-02 スタビコン ライフ サイエンシズ プライベート リミテッド 非クルクミノイドの水溶性粒子とクルクミノイドの水溶性粒子から構成される製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568547A (en) * 1979-08-30 1986-02-04 Herschler R J Solid pharmaceutical compositions comprising MSM and their production
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
FR2710535B1 (fr) * 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
ES2233971T3 (es) 1995-07-21 2005-06-16 Daiichi Pharmaceutical Co., Ltd. Procedimiento de produccion de una preparacion granular.
ES2173364T5 (es) * 1997-10-27 2005-04-16 DR. GERGELY & CO. Composicion efervescente con extracto vegetal.
CA2360418C (en) * 1999-01-12 2009-05-26 Steven William Booth Spheronised self-emulsifying system for hydrophobic and water-sensitive agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
SE0200154D0 (sv) * 2002-01-21 2002-01-21 Galenica Ab New process
DE10300325A1 (de) * 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
JP2006517929A (ja) * 2003-02-19 2006-08-03 ハー・ルンドベック・アクチエゼルスカベット 溶融アグロメレーションを用いてアグロメレートを製造する方法

Also Published As

Publication number Publication date
WO2003061630A1 (en) 2003-07-31
US20050084526A1 (en) 2005-04-21
EP1467713A1 (en) 2004-10-20
EP1467708A1 (en) 2004-10-20
US20060182799A1 (en) 2006-08-17
US7422757B2 (en) 2008-09-09
WO2003061627A1 (en) 2003-07-31
WO2003061630A8 (en) 2004-12-09
EP1467713B1 (en) 2014-06-04

Similar Documents

Publication Publication Date Title
WO2003061630A8 (en) Tabletting process
TW200510375A (en) New compounds
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
HRP20090194T1 (hr) Suha granulirana kompozicija koja sadrži emtricitabin i tenofovir df
MXPA05002942A (es) Forma de dosificacion oral de liberacion modificada.
ES2061623T3 (es) Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
MY142120A (en) Stable tablet formulation of tetrahydrobiopterin
TW200633730A (en) Oral disintegrating dosage forms
NO20074092L (no) Tabletter for forbedret legemiddel dispersibilitet
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
BR0309298A (pt) Método para estabilizar comprimidos de cloreto de bupropion
WO2007010400A3 (en) Gastroretentive formulations and manufacturing process thereof
EP1622586A4 (en) METHOD FOR PRODUCING TANNATE TABLETS, CAPSULES OR OTHER SOLID DOSAGE FORMS
EA200602175A1 (ru) Агломерация кальцийсодержащего соединения прессованием на валках
GB0404586D0 (en) Improvements in or relating to organic materials
TW200628448A (en) Carbazole compounds
MX2007006322A (es) Dihidrato de clorhidrato de (s)-(-)-1-(4-fluoroisoquinolin-5-il) sulfonil-2-metil-1,4-homopiperazina.
GR1004193B (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
WO2005115414A3 (en) Orally-administrable compositions comprising stable amorphous calcium carbonate
ES8301629A1 (es) "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".
WO2009135950A3 (en) Process for preparing a tablet containing excipients
DE60220551D1 (de) Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
EA200301282A1 (ru) Гранулярные препараты габоксадола
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration